Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

November 30, 2015

Conditions
Human Immunodeficiency VirusHIVVertical Infection Transmission
Trial Locations (2)

Unknown

Children's Hospital of Eastern Ontario, Ottawa

M5G1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Canadian Foundation for AIDS Research (CANFAR)

OTHER

collaborator

Children's Hospital of Eastern Ontario

OTHER

collaborator

Unity Health Toronto

OTHER

collaborator

Mount Sinai Hospital, Canada

OTHER

lead

The Hospital for Sick Children

OTHER

NCT02166502 - Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection | Biotech Hunter | Biotech Hunter